Tumor Size, Histology, and Survival after Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer

Vignesh Raman,Oliver K Jawitz,Marcelo Cerullo,Soraya L Voigt,Kristen E Rhodin,Chi-Fu Jeffrey Yang,Thomas A D'Amico,David H Harpole,Christopher R Kelsey,Betty C Tong,Oliver K. Jawitz,Soraya L. Voigt,Kristen E. Rhodin,Thomas A. D’Amico,David H. Harpole,Christopher R. Kelsey,Betty C. Tong

DOI: https://doi.org/10.1097/sla.0000000000004730

IF: 13.787

2021-01-07

Annals of Surgery

Abstract:Although SABR is increasingly emerging as an alternative to surgery for node-negative non-small cell lung cancer, there is poor understanding of patients who may most benefit SABR compared to surgery.

surgery